Urszula Wojtyra
Associate, Toronto
Barrister and Solicitor


Phone: 416.593.5514
Fax: 416.591.1690
Download V-Card
Ontario Bar 2008
  • University of Guelph B.Sc. Hons. (Applied Biochemistry) 1998
  • University of Toronto M.Sc. (Biochemistry) 2003; thesis titled Characterization of the N-Terminal Domain of the Chaperone ClpX
  • University of Toronto J.D. 2007

Urszula Wojtyra practices in the field of life sciences (pharmaceuticals, biologics, medical devices, natural health products). She regularly represents innovative pharmaceutical and biopharmaceutical companies in complex patent litigation, including patent infringement actions and proceedings under the Patented Medicines (Notice of Compliance) Regulations. Urszula has represented clients before both the Federal Court and the Federal Court of Appeal of Canada. Her extensive experience and skills in strategic litigation management makes Urszula a valued and key member of litigation teams. Most recently, Urszula was a member of the Smart & Biggar team that successfully represented AstraZeneca in its patent infringement action against Apotex: AstraZeneca Canada Inc. v Apotex Inc., 2015 FC 322 (LOSEC, omeprazole).

Urszula also advises clients on regulatory due diligence, regulatory compliance issues (under the Food and Drugs Act and associated regulations) and has broad expertise in regulatory matters in Canada, including related to biologics.

Prior to attending law school, Urszula obtained her Master of Science in biochemistry from the University of Toronto and worked in an immunology research laboratory in Toronto’s Hospital for Sick Children. Her technical expertise in biochemistry, chemistry, molecular biology, immunology, genetics, and medicine further empowers Urszula to successfully advise and represent her clients.

Urszula is a regular contributor to Rx IP Update, the firm's monthly pharmaceutical and biopharmaceutical intellectual property and regulatory newsletter. She is also the Chair for the IPIC Competition Law Committee.

Rankings and recognition

Recognized as a ‘Rising Star’ in the 2016 edition of LMG Rising Stars under Life Sciences

Life Sciences
Chemical & Industrial Biotechnology
Life Sciences — Regulatory & Compliance

AstraZeneca Canada Inc v Apotex Inc2015 FCA 158 (CanLII) — 2015-07-06 (NEXIUM, esomeprazole)

AstraZeneca Canada Inc v Apotex Inc2015 FC 671 (CanLII) — 2015-05-25 (LOSEC, omeprazole)

AstraZeneca Canada Inc v Apotex Inc2015 FC 322 (CanLII) — 2015-03-16 (LOSEC, omeprazole)

AstraZeneca Canada Inc v Apotex Inc2014 FC 638 (CanLII) — 2014-07-02  (NEXIUM, esomeprazole)

AstraZeneca Canada Inc v Apotex Inc2011 FC 862 (CanLII) — 2011-07-11 (LOSEC, omeprazole)

AstraZeneca Canada Inc v Novopharm Limited2009 FC 902 (CanLII) — 2009-09-11 (CRESTOR, rosuvastatin)


  • Associate, Intellectual Property Institute of Canada; member of the Competition Law Committee; member of the Women in IP Network
  • Member, Toronto Intellectual Property Group
  • Member, The Advocates' Society


web design toronto Rebel Trail